Clin Cancer Res 2020 Jan 1
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer.   

Related Questions

In which situations would you consider this a reasonable treatment option?